Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
about
Role of Phosphodiesterase 5 and Cyclic GMP in HypertensionRegulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaRNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclaseGenetic modification of hypertension by sGCα1New insights into the role of soluble guanylate cyclase in blood pressure regulationPAS-mediated Dimerization of Soluble Guanylyl Cyclase Revealed by Signal Transduction Histidine Kinase Domain Crystal StructureCrystal structure of the signaling helix coiled-coil domain of the β1 subunit of the soluble guanylyl cyclaseChaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclaseAnti-peroxynitrite treatment ameliorated vasorelaxation of resistance arteries in aging rats: involvement with NO-sGC-cGKs pathwayExquisite sensitivity to subsecond, picomolar nitric oxide transients conferred on cells by guanylyl cyclase-coupled receptors.Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.Sensitivity to Sevoflurane anesthesia is decreased in mice with a congenital deletion of Guanylyl Cyclase-1 alpha.Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.Endothelial nitric oxide synthase transgenic models of endothelial dysfunctionOxygen mediates vascular smooth muscle relaxation in hypoxiaSoluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury.Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systemsTargeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vesselsPhosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertensionBiphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase.Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.Disruption of guanylyl cyclase-G protects against acute renal injuryAlpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activityInterstitial cells of Cajal contain signalling molecules for transduction of nitrergic stimulation in guinea pig caecumGuanylyl cyclase structure, function and regulation.Concepts of neural nitric oxide-mediated transmission.Soluble guanylate cyclase modulates alveolarization in the newborn lung.sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.Gender-specific modulation of the response to arterial injury by soluble guanylate cyclase α1.What is the real physiological NO concentration in vivo?Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.Toward a better understanding of gastrointestinal nitrergic neuromuscular transmission.
P2860
Q26748049-4A52A823-3E50-4CA8-A909-43B9888B3D47Q26861763-9A969602-8AB5-4D8B-8797-BCB3C28F75A7Q27001569-5A11780F-0964-4A59-815B-7F8679E5AF1CQ27001632-6C248106-1AEF-47F2-82AF-D65DEEB300DCQ27021422-8C645C5F-8D86-4053-8AA6-8EBA3BEB95DEQ27649070-58C4101E-3585-46E7-98C6-E086FAEADBBCQ27659219-CED11D5D-15B6-4C56-AB1E-8A9F4C8BDF1FQ28248976-A35C25DC-725D-4148-A4B8-6186EE624A77Q28541815-58BDA4D9-A2AE-45FD-9781-AE2B4011D2D0Q30497748-244E349F-77D8-49CB-B1B7-DA6ADE230384Q33406588-76A6546C-578A-43EC-8227-8C7AF3D81199Q33596457-4DA1F118-B94A-4CBD-9C3C-20128AA91508Q33801187-E0CC8273-7E93-4CC8-8110-32E8C6DCE484Q34214656-1B6A746D-0C96-4509-89D5-6DEB8CEC1D77Q34286604-63DFA38A-24D2-4B48-A661-4EED4027AAD4Q34603164-0929E900-F9AE-429F-AAC5-136E1411182DQ34618219-336D10DC-49A9-4D1A-8AAF-44D7975667E8Q34686759-AB91A686-FB1F-4F55-9339-34DBBB068D5AQ34784680-CA83A906-C567-4F3D-A01E-3CA76E537F6DQ34892722-075AF9A7-2952-4D84-ADB5-F0C335E7E3F2Q34981386-488F72F6-59D5-46F4-9D95-B8FF0D5DDBD8Q35009484-76B5D6A9-F2C7-4571-A5B8-6E6B361DC367Q35049171-8FA1285F-CDD9-40D6-870D-98816007C24CQ35266258-438704E5-AC5A-4EED-B3B8-FB8B993A20BFQ35778348-BEB9C3E2-63B1-463D-BEE9-404A7AB94D56Q36000019-E8845E76-1C33-4148-834B-8080A046565EQ36380981-F0F0068E-162F-4851-9E43-46DFAC78AB42Q36424922-AF59E230-10D6-49A9-BCD2-66CAC8F6D41FQ36532454-6CF5563C-DB5D-4AAA-B694-E9A24E81C3AFQ36677353-8BD26DE1-99B8-40F6-B94C-3D6AEB664C2FQ36678534-98A944C2-9FAE-4090-BB8A-B2F128EF570CQ36692154-64846D66-5EA1-4250-89FB-9A7CE3A495D4Q36867727-8777E64A-8616-4B26-BE50-897118885965Q37029494-D5B71F02-4BA6-45DC-B2CD-310FD0F9B4CEQ37234894-82F2388E-A7DE-4E28-B7F9-DED931D98EB7Q37298332-7BEA09B0-F090-46A0-8498-62DE4D1046D1Q37346565-0975605D-A7F9-4B8B-BF29-527B1917931DQ37551307-D880EA64-387D-4823-A540-855789F47DF3Q37634112-C883B5DD-8199-456D-9A64-B6C82E6E9124Q38211701-28EA3F6E-384E-4707-82F5-995AB257AF27
P2860
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@ast
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@en
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@nl
type
label
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@ast
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@en
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@nl
prefLabel
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@ast
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@en
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@nl
P2093
P2860
P3181
P356
P1476
Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system
@en
P2093
Andreas Friebe
Doris Koesling
Evanthia Mergia
Michael Russwurm
Oliver Dangel
P2860
P304
P3181
P356
10.1172/JCI27657
P407
P577
2006-05-04T00:00:00Z